NEKTAR THERAPEUTICS — Director's Dealing 2018

Feb 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2018-01-31

Reporting Person: Nicholson John (SVP & Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-31	Common Stock	M	120000	$11.34	Acquired	392536	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-31	Stock Option	$11.34	M	120000	Disposed	2018-02-01	Common Stock (120000)	Direct

Footnotes

F1: This transaction was made for stock options scheduled to expire on February 1, 2018.